These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1269692)

  • 1. [Effect of the production process on the quality of drugs].
    Murav'ev IO
    Farm Zh; 1976; (2):20-7. PubMed ID: 1269692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
    Hänselmann B; Voigt R
    Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs in tablets].
    Borzunov EE
    Farm Zh; 1976; (4):17-21. PubMed ID: 793856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biopharmaceutical aspects of pharmaceutical technology].
    Thoma K
    Pharmazie; 1981 Mar; 36(3):185-93. PubMed ID: 7279982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biopharmaceutical aspects of scientific research and the teaching of drug technology].
    Murav'ev IO
    Farm Zh; 1977; (2):38-45. PubMed ID: 328295
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of formulation on drug action.
    Münzel K
    Pharm Acta Helv; 1971 Sep; 46(9):513-38. PubMed ID: 5099398
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems posed by formulation of dry forms with delayed action administered orally].
    Delporte JP
    Farmaco Prat; 1974 Aug; 29(8):407-32. PubMed ID: 4849495
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the feasibility of oral controlled release in an exploratory development setting.
    Thombre AG
    Drug Discov Today; 2005 Sep; 10(17):1159-66. PubMed ID: 16182208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the physiological availability of drug substances in capsules].
    Mikhaĭlova GS
    Farmatsiia; 1975; 24(1):78-82. PubMed ID: 770209
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on index for formulation optimization of sustained or controlled released dosage forms].
    Hong YL; Feng Y; Xu DS
    Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(1):15-7. PubMed ID: 16548158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems of control of polymers used in drug technology].
    Krówczyński L
    Polim Med; 1984; 14(1-4):5-12. PubMed ID: 6533635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of biopharmaceutical parameters in drug development (author's transl)].
    Thoma K
    Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of conditions for the production of tablets of drugs containing plant extracts. II].
    Proshunina DV
    Farm Zh; 1968; 23(1):39-45. PubMed ID: 5699873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Suggestions and recommendations for standardization of the systemic "routine" control during the production of the pharmaceutical dosage forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Mar; 110(3):131-46 contd. PubMed ID: 5561774
    [No Abstract]   [Full Text] [Related]  

  • 17. Hot-melt extrusion.
    Jana S; Miloslava R
    Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients.
    Subert J; Cizmárik J
    Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.